ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 791,94
1,44%
DAX
18 518,03
-0,44%
Brent Oil
83,435
-1,07%
Bitcoin
64 477,58
-0,58%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Hutchison China Meditech Ltd (0J7G)

  7. Hutchison China Meditech Ltd (0J7G) Actualités

0J7G

Hutchison China Meditech (0J7G)

Hutchison China Meditech Ltd
De:
Trier par:
 Showing the most relevant articles for your search:LSE:0J7G
DateHeureSourceTitreSymboleSociété
01/07/202112h00RNS Non-RegulatoryHutchmed (China) Limited US FDA Accepts NDA Filing for SurufatinibLSE:0J7GHutchison China Meditech Ltd
30/06/202111h02UK RegulatoryHutchmed (China) Limited Holdings in CompanyLSE:0J7GHutchison China Meditech Ltd
30/06/202111h01UK RegulatoryHutchmed (China) Limited Total Voting RightsLSE:0J7GHutchison China Meditech Ltd
30/06/202111h00UK RegulatoryHutchmed (China) Limited Closing of Global Offering and Hong Kong ListingLSE:0J7GHutchison China Meditech Ltd
29/06/202108h00UK RegulatoryHutchmed (China) Limited Blocklisting Six Monthly ReturnLSE:0J7GHutchison China Meditech Ltd
23/06/202116h21UK RegulatoryHutchmed (China) Limited HUTCHMED Announces Pricing of Global OfferingLSE:0J7GHutchison China Meditech Ltd
22/06/202119h22UK RegulatoryHutchmed (China) Limited Savolitinib approved in China for lung cancerLSE:0J7GHutchison China Meditech Ltd
18/06/202117h05UK RegulatoryHutchmed (China) Limited HUTCHMED Announces NMPA Approval of SurufatinibLSE:0J7GHutchison China Meditech Ltd
18/06/202108h01UK RegulatoryHutchmed (China) Limited HUTCHMED Launches Hong Kong IPOLSE:0J7GHutchison China Meditech Ltd
18/06/202108h00UK RegulatoryHutchmed (China) Limited Disclosure UpdateLSE:0J7GHutchison China Meditech Ltd
20/05/202108h00RNS Non-RegulatoryHutchmed (China) Limited Clinical Data to be Presented at ASCO21LSE:0J7GHutchison China Meditech Ltd
17/05/202108h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED to Host Company UpdateLSE:0J7GHutchison China Meditech Ltd
07/05/202113h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED to Attend Upcoming Investor ConferencesLSE:0J7GHutchison China Meditech Ltd
04/05/202109h00UK RegulatoryHutchison China Meditech Limited Change of Company NameLSE:0J7GHutchison China Meditech Ltd
04/05/202108h00RNS Non-RegulatoryHutchison China Meditech Limited Surufatinib FDA Rolling NDA Submission CompletedLSE:0J7GHutchison China Meditech Ltd
30/04/202117h41UK RegulatoryHutchison China Meditech Limited Second Price Monitoring ExtnLSE:0J7GHutchison China Meditech Ltd
30/04/202117h35UK RegulatoryHutchison China Meditech Limited Price Monitoring ExtensionLSE:0J7GHutchison China Meditech Ltd
29/04/202108h00RNS Non-RegulatoryHutchison China Meditech Limited Phase II Registration Study of HMPL-689 InitiatedLSE:0J7GHutchison China Meditech Ltd
28/04/202115h20UK RegulatoryHutchison China Meditech Limited Result of AGMLSE:0J7GHutchison China Meditech Ltd
23/04/202108h00UK RegulatoryHutchison China Meditech Limited Vesting of awards under Long Term Incentive PlanLSE:0J7GHutchison China Meditech Ltd
14/04/202111h30UK RegulatoryHutchison China Meditech Limited Notification of Dilution of Voting RightsLSE:0J7GHutchison China Meditech Ltd
08/04/202109h30UK RegulatoryHutchison China Meditech Limited $100m Investment by Baring Private Equity AsiaLSE:0J7GHutchison China Meditech Ltd
31/03/202108h00UK RegulatoryHutchison China Meditech Limited Total Voting RightsLSE:0J7GHutchison China Meditech Ltd
29/03/202110h30UK RegulatoryHutchison China Meditech Limited Grant of LTIP Awards and Share OptionsLSE:0J7GHutchison China Meditech Ltd
29/03/202108h00RNS Non-RegulatoryHutchison China Meditech Limited Initiates International Phase I Trials of HMPL-306LSE:0J7GHutchison China Meditech Ltd
26/03/202108h00UK RegulatoryHutchison China Meditech Limited Annual Financial ReportLSE:0J7GHutchison China Meditech Ltd
24/03/202114h30UK RegulatoryHutchison China Meditech Limited Agreement to Divest Non-Core OTC Joint VentureLSE:0J7GHutchison China Meditech Ltd
24/03/202108h00RNS Non-RegulatoryHutchison China Meditech Limited Phase Ib/II Trial of Surufatinib with TislelizumabLSE:0J7GHutchison China Meditech Ltd
04/03/202116h15UK RegulatoryHutchison China Meditech Limited Publication of Form 20-FLSE:0J7GHutchison China Meditech Ltd
04/03/202113h00UK RegulatoryHutchison China Meditech Limited Final Results, Business Update and Name ChangeLSE:0J7GHutchison China Meditech Ltd
 Showing the most relevant articles for your search:LSE:0J7G

Dernières Valeurs Consultées

TSXV
ISD
iSign Media Solutions
LSE
TIP5
Ishs $ Tps 0-5
COIN
SHIBUSD
SHIBA INU
NYSE
HTGC
Hercules Capital
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés